Vancomycin MIC Testing Methods for Staphylococcus aureus
Laboratories measure vancomycin activity against Staphylococcus aureus with MIC tests. MIC means the lowest drug concentration that stops visible growth. Accurate results matter because vancomycin remains a key treatment for serious MRSA infections. Disk diffusion does not work well for this combination. Therefore, labs rely on MIC-based methods.
Why MIC testing is required
Vancomycin diffuses poorly in agar. As a result, zone diameters fail to separate susceptible strains from isolates with reduced susceptibility. CLSI therefore advises against vancomycin disk testing for S. aureus. Instead, labs report an MIC. That value guides therapy and helps detect VISA and VRSA.
Reference broth microdilution
Broth microdilution is the reference method. Technologists prepare cation-adjusted Mueller-Hinton broth. They add a standard inoculum of about 5 × 10^5 CFU/mL. They then expose the isolate to doubling dilutions of vancomycin. After 24 hours at 35°C, they read the lowest well without growth. This method defines official breakpoints. It also serves as the benchmark for other assays.
Agar dilution
Agar dilution places vancomycin into Mueller-Hinton agar plates. Workers spot a standardized inoculum on each plate. After incubation, they record the lowest concentration that prevents growth. The method suits batch testing. However, it needs more media preparation than microdilution.
Gradient diffusion strips
Etest and similar strips create a stable vancomycin gradient on agar. A technician places the strip on an inoculated Mueller-Hinton plate. After 24 hours, an ellipse of inhibition appears. The MIC is the value where the ellipse meets the strip. This method is practical for routine labs. Still, readers must follow the manufacturer’s rules for trailing endpoints.
Automated systems
VITEK 2, Phoenix, and MicroScan estimate vancomycin MIC from growth curves. These systems speed reporting. They also reduce manual steps. Yet they can miss some isolates with MIC values near 2 µg/mL. Therefore, labs should confirm unexpected or borderline results with a reference or gradient method.
Vancomycin screen agar
Brain-heart infusion agar with 6 µg/mL vancomycin screens for reduced susceptibility. Growth on this plate flags isolates that need full MIC testing. The screen does not replace an MIC. It only sorts isolates that deserve extra work.
Special issue: hVISA
Some strains contain mixed subpopulations. These heteroresistant VISA isolates may look susceptible on routine MIC tests. Population analysis profile–area under the curve testing can detect them. That method is specialized. Clinical labs usually reserve it for treatment failure or research.
Reading and interpretation
CLSI lists S. aureus as susceptible at MIC ≤2 µg/mL. Intermediate or VISA isolates fall at 4–8 µg/mL. Resistant or VRSA isolates show MIC ≥16 µg/mL. EUCAST uses similar clinical categories. Incubation time, inoculum density, and media quality all affect the result. A 16-hour read can miss reduced susceptibility. A 24-hour read is therefore essential.
Quality control
Labs must test control strains with each run. S. aureus ATCC 29213 is the usual control. Results should fall inside accepted MIC ranges. Staff should also watch for vancomycin MIC creep over time. Rising modal MIC values can signal emerging reduced susceptibility in the local population.
Practical takeaway
Use a validated MIC method for every clinically important S. aureus isolate when vancomycin is considered. Confirm borderline results. Report the numeric MIC with the interpretive category. Link the result to clinical review, especially in bacteremia and other deep infections.